The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism

Department of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Genes & development (Impact Factor: 12.64). 12/2010; 24(24):2784-99. DOI: 10.1101/gad.1985910
Source: PubMed

ABSTRACT Glucose and glutamine serve as the two primary carbon sources in proliferating cells, and uptake of both nutrients is directed by growth factor signaling. Although either glucose or glutamine can potentially support mitochondrial tricarboxylic acid (TCA) cycle integrity and ATP production, we found that glucose deprivation led to a marked reduction in glutamine uptake and progressive cellular atrophy in multiple mammalian cell types. Despite the continuous presence of growth factor and an abundant supply of extracellular glutamine, interleukin-3 (IL-3)-dependent cells were unable to maintain TCA cycle metabolite pools or receptor-dependent signal transduction when deprived of glucose. This was due at least in part to down-regulation of IL-3 receptor α (IL-3Rα) surface expression in the absence of glucose. Treatment of glucose-starved cells with N-acetylglucosamine (GlcNAc) to maintain hexosamine biosynthesis restored mitochondrial metabolism and cell growth by promoting IL-3-dependent glutamine uptake and metabolism. Thus, glucose metabolism through the hexosamine biosynthetic pathway is required to sustain sufficient growth factor signaling and glutamine uptake to support cell growth and survival.

Download full-text


Available from: Hilary Coller, Aug 02, 2015
  • Source
    • "Additionally, modifications of the O-linked N-acetylglucosamine (GlcNAc) type have been reported to occur on histone H2B at serine 112. The glycosylation reaction is catalyzed by O-GlcNAc transferase (OGT) [42] [43]. The implication of this type of epigenetic modification is not fully understood and warrants further investigation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer cells adapt their metabolism to support proliferation and survival. A hallmark of cancer, this alteration is characterized by dysfunctional metabolic enzymes, changes in nutrient availability, tumor microenvironment and oncogenic mutations. Metabolic rewiring in cancer is tightly connected to changes at the epigenetic level. Enzymes that mediate epigenetic status of cells catalyze posttranslational modifications of DNA and histones and influence metabolic gene expression. These enzymes require metabolites that are used as cofactors and substrates to carry out reactions. This interaction of epigenetics and metabolism constitutes a new avenue of cancer biology and could lead to new insights for the development of anti-cancer therapeutics.
    Cancer letters 10/2013; 356(2). DOI:10.1016/j.canlet.2013.09.043 · 5.62 Impact Factor
  • Source
    • "Protein modifications are routinely identified and proteins are being quantified (Cohen et al., 2008; Uhlen et al., 2010). In parallel, other studies are characterizing the metabolome (Jain et al., 2012) and metabolic flux through pathways in cancer (Wellen et al., 2010; Locasale et al., 2011). Genomic, metabolomic, and phenotyping studies yield valuable data, but it is challenging to integrate the datasets for deeper insight. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The importance of metabolism in cancer is becoming increasingly apparent with the identification of metabolic enzyme mutations and the growing awareness of the influence of metabolism on signaling, epigenetic markers, and transcription. However, the complexity of these processes has challenged our ability to make sense of the metabolic changes in cancer. Fortunately, constraint-based modeling, a systems biology approach, now enables one to study the entirety of cancer metabolism and simulate basic phenotypes. With the newness of this field, there has been a rapid evolution of both the scope of these models and their applications. Here we review the various constraint-based models built for cancer metabolism and how their predictions are shedding new light on basic cancer phenotypes, elucidating pathway differences between tumors, and dicovering putative anti-cancer targets. As the field continues to evolve, the scope of these genome-scale cancer models must expand beyond central metabolism to address questions related to the diverse processes contributing to tumor development and metastasis.
    Frontiers in Physiology 09/2013; 4:237. DOI:10.3389/fphys.2013.00237 · 3.50 Impact Factor
  • Source
    • "These data support the idea that dMyc in the FB is able to reduce the level of sugars in the hemolymph via a remote control of dilps and through a tissue autonomous regulation of glucose uptake in FB. In vertebrates, increase in glucose metabolism is associated to glutamine uptake to promote cell survival (Wellen et al., 2010), in addition, c-myc induces the consumption of glutamine to favor growth in cancer cells (Wise et al., 2008). In cg-dMyc FBs, we found increased expression of Glutaminase (CG42708) and of Glutamine synthetase1 (GS1) mRNAs, suggesting that dMyc may control glutamine metabolism in Drosophila FB. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Drosophila dMyc (dMyc) is known for its role in cell-autonomous regulation of growth. Here we address its role in the fat body (FB), a metabolic tissue that functions as a sensor of circulating nutrients to control the release of Drosophila Insulin-like peptides (Dilps) from the brain influencing growth and development. Our results show that expression of dMyc in the FB affects development and animal size. Expression of dMyc, but not of CycD/cdk4 or Rheb, in the FB diminishes the ability to retain Drosophila Insulin-like peptide-2 (DILP2) in the brain during starvation, suggesting that expression of dMyc mimics the signal that remotely controls the release of Dilps into the hemolymph. dMyc also affects glucose metabolism and increases the transcription of Glucose-transporter-1 mRNA, and of Hexokinase and Pyruvate-Kinase mRNAs, key regulators of glycolysis. These animals are able to counteract the increased levels of circulating trehalose induced by a high sugar diet leading to the conclusion that dMyc activity in the FB promotes glucose disposal. dMyc expression induces cell autonomous accumulation of triglycerides, which correlates with increased levels of Fatty Acid Synthase and Acetyl CoA Carboxylase mRNAs, enzymes responsible for lipid synthesis. We also found the expression of Stearoyl-CoA desaturase, Desat1 mRNA significantly higher in FB overexpressing dMyc. Desat1 is an enzyme that is necessary for monosaturation and production of fatty acids, and its reduction affects dMyc's ability to induce fat storage and resistance to animal survival.
    Developmental Biology 04/2013; 379(1). DOI:10.1016/j.ydbio.2013.04.008 · 3.64 Impact Factor
Show more